- Patent Foramen Ovale: Story Closed?
-
Köhrmann , Schellinger PD, Tsivgoulis G, Steiner T
- KMID: 2438647
- J Stroke.
- 2019 Jan;21(1):23-30.
- doi: 10.5853/jos.2018.03097
The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal
-
Schellinger PD, Tsivgoulis G, Steiner T, Köhrmann
- KMID: 2428764
- J Stroke.
- 2018 Sep;20(3):281-291.
- doi: 10.5853/jos.2018.02537
The authors review the current status of percutaneous left atrial appendage (LAA) occlusion therapy in patients with atrial fibrillation with the goal to prevent ischemic stroke and systemic embolism and... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
-
Steiner T, Köhrmann , Schellinger PD, Tsivgoulis G
- KMID: 2428765
- J Stroke.
- 2018 Sep;20(3):292-301.
- doi: 10.5853/jos.2018.02250
Oral anticoagulant-associated intracerebral hemorrhage (OAC-ICH) accounts for nearly 20% of all ICH. The number of patients with an indication for oral anticoagulant therapy (OAT) increases with increasing age. OAT became... -
- CITED
-
- Close
- SHARE
-
- Close
